GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stratec SE (OTCPK:SRBZF) » Definitions » Price-to-Operating-Cash-Flow

Stratec SE (Stratec SE) Price-to-Operating-Cash-Flow : 42.39 (As of May. 01, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Stratec SE Price-to-Operating-Cash-Flow?

As of today (2024-05-01), Stratec SE's share price is $72.9551. Stratec SE's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.72. Hence, Stratec SE's Price-to-Operating-Cash-Flow Ratio for today is 42.39.

The historical rank and industry rank for Stratec SE's Price-to-Operating-Cash-Flow or its related term are showing as below:

SRBZF' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 12.38   Med: 30.25   Max: 149.32
Current: 26.89

During the past 13 years, Stratec SE's highest Price-to-Operating-Cash-Flow Ratio was 149.32. The lowest was 12.38. And the median was 30.25.

SRBZF's Price-to-Operating-Cash-Flow is ranked worse than
60.72% of 443 companies
in the Medical Devices & Instruments industry
Industry Median: 21.72 vs SRBZF: 26.89

Stratec SE's Cash Flow from Operations per share for the three months ended in Dec. 2023 was $0.78. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.72.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Stratec SE was 89.30% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -15.20% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 2.50% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was -2.80% per year.

During the past 13 years, Stratec SE's highest 3-Year average Operating Cash Flow per Share Growth Rate was 164.30% per year. The lowest was -47.00% per year. And the median was 7.10% per year.


Stratec SE Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Stratec SE's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stratec SE Price-to-Operating-Cash-Flow Chart

Stratec SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.60 46.85 26.44 96.09 28.50

Stratec SE Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 96.09 49.25 - - 28.50

Competitive Comparison of Stratec SE's Price-to-Operating-Cash-Flow

For the Medical Devices subindustry, Stratec SE's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stratec SE's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stratec SE's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Stratec SE's Price-to-Operating-Cash-Flow falls into.



Stratec SE Price-to-Operating-Cash-Flow Calculation

Stratec SE's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=72.9551/1.721
=42.39

Stratec SE's Share Price of today is $72.9551.
Stratec SE's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.72.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Stratec SE Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Stratec SE's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Stratec SE (Stratec SE) Business Description

Traded in Other Exchanges
Address
Gewerbestrasse 37, Birkenfeld, RP, DEU, 75217
Stratec SE designs and manufactures automated analyzer systems for laboratory data management and solutions for molecular diagnostic sample preparation and stabilization. Its business segments are Instrumentation, Diatron and Smart Consumables. Its Instrumentation segment is engaged in designing and manufacturing automated analyzer systems for clinical diagnostics and biotechnology customers. The Diatron segment comprises the business with systems, system components, consumables, and tests in the low throughput hematology and clinical chemistry segment. Its Smart Consumables segment is engaged in developing and selling scientific materials, such as nucleic acid purification. The company generates maximum revenue from the Instrumentation segment.

Stratec SE (Stratec SE) Headlines

From GuruFocus